Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Watson Pharma Stands Tall
Daily Markets
Saturday, August 27, 2011 - 1:29pm
tags:
Watson Pharmaceuticals
5 Healthcare Stocks Investors Are Tossing Away
Wall St Cheat Sheet
Saturday, August 27, 2011 - 1:27pm
tags:
Merck, Eli Lilly, Abbott Laboratories, Patterson Companies
Insider Buying On Impax After Parkinson's Drug Study Results
Seeking Alpha
Saturday, August 27, 2011 - 1:07pm
tags:
Impax Labs, Parkinson's Disease, IPX066, GSK
10 Most Popular Drug Companies That Hedge Funds Love
Seeking Alpha
Saturday, August 27, 2011 - 1:06pm
tags:
JNJ, Pfizer, Sanofi, Merck, Abbott Laboratories, Bristol-Myers Squibb, Eli Lilly, Novartis, Impax Labs, Anthera
Time to Sell Bristol-Myers Squibb?
Motley Fool
Saturday, August 27, 2011 - 1:04pm
tags:
Bristol-Myers Squibb
Vical: Making Progress In The Area Of HSV-2 Vaccines
Seeking Alpha
Saturday, August 27, 2011 - 1:02pm
tags:
Vical, Allovectin, herpes simplex 2, herpes simplex vaccine
Pfizer Wins Approval For Xalkori, Lung Cancer Drug That Heralds Age Of Expensive, Personalized Medicines
Forbes
Saturday, August 27, 2011 - 1:01pm
tags:
Pfizer, personalized medicine, Xalkori, lung cancer, crizotinib
4 Oversold Biotech Stocks Being Snapped Up By Insiders
Seeking Alpha
Saturday, August 27, 2011 - 12:59pm
tags:
Complete Genomics, MannKind, Corcept Therapeutics, Medivation
Does Affymetrix Hit Buffett's Target?
Motley Fool
Saturday, August 27, 2011 - 12:57pm
tags:
Affymetrix
Biotech Sector Sees An Uptick As Investor Interest Returns
Forbes
Saturday, August 27, 2011 - 12:56pm
tags:
Roth Capital Partners Initiates Research Coverage of StemCells, Inc. With Buy Recommendation
Yahoo/GlobeNewswire
Saturday, August 27, 2011 - 12:55pm
tags:
StemCells
Encouraging Pipelines From Pluristem and Fibrocell Science Gain Attention
Yahoo/MarketWire
Saturday, August 27, 2011 - 12:54pm
tags:
Pluristem, Fibrocell Science
Cipla eyes alliances to grow in emerging markets
Fierce Pharma
Friday, August 26, 2011 - 11:36am
tags:
emerging markets, Cipla
Warner Chilcott Stock Hits New 52-Week Low (WCRX)
TheStreet.com
Friday, August 26, 2011 - 11:34am
tags:
Warner Chilcott
The Long Term Bullish Case for Pharma
Forbes
Friday, August 26, 2011 - 11:33am
tags:
pharma industry
J&J's XR pain drug gets FDA nod
Fierce Biotech
Friday, August 26, 2011 - 10:30am
tags:
FDA, Nucynta, JNJ, painkillers
How A Pharmaceutical Giant Is Battling Malnutrition On The Ground In Haiti
Fast Company
Friday, August 26, 2011 - 9:26am
tags:
Abbott Laboratories, malnutrition, Haiti
Baxter to Acquire Baxa Corp
Contract Pharma
Friday, August 26, 2011 - 9:19am
tags:
Baxa, Baxter, M&A, drug delivery
Biosimilars: physicians cite concerns over supporting data
Pharma Times, UK
Friday, August 26, 2011 - 9:18am
tags:
biosimilars, physicians
6 Healthcare Stocks Primed For A Rebound
Seeking Alpha
Friday, August 26, 2011 - 9:16am
tags:
Apricus Biosciences, CytRx, Geron, Dendreon, SIGA technologies, ImmunoCellular

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.